QTEC vs RYT

Both QTEC and RYT are ETFs. QTEC has a higher 5-year return than RYT (12.94% vs 12.93%). QTEC has a higher expense ratio than RYT (0.57% vs 0.4%). Below is the comparison between QTEC and RYT.

Together with FinMasters
Stock Wars
Pick any two stocks and find out how much money each would've made you had you purchased them at the same time.
QTEC RYT
Security Type ETF ETF
Finny Score 67 80
Category Technology Technology
Family First Trust Guggenheim
Net Assets N/A N/A
Expense Ratio 0.57% 0.40%
Management Style passive (index-based) passive (index-based)
Dividend Yield 0.20% 0.64%
Underlying Index NASDAQ-100 Technology Index S&P 500 Equal Weight Index Technology
YTD Return 35.82% 19.34%
1-Year Return 28.91% 17.05%
3-Year Return 8.28% 15.06%
5-Year Return 12.94% 12.93%
10-Year Return 16.79% 17.54%

QTEC

QTEC description

First Trust Exchange-Traded Fund - First Trust NASDAQ-100-Technology Sector Index Fund is an exchange traded fund launched and managed by First Trust Advisors LP. The fund invests in public equity markets of global region. It invests in stocks of companies operating across information technology sectors. It invests in growth and value stocks of large-cap companies. It seeks to track the performance of the NASDAQ-100 Technology Sector Index, by using full replication technique. First Trust Exchange-Traded Fund - First Trust NASDAQ-100-Technology Sector Index Fund was formed on April 19, 2006 and is domiciled in the United States.

QTEC performance & returns

YTD Return 35.82%
1-Month Return -1.51%
3-Month Return -0.25%
1-Year Return 28.91%
3-Year Return 8.28%
5-Year Return 12.94%
10-Year Return 16.79%
QTEC expense ratio is 0.57%.

QTEC holdings

Top 10 Holdings (29.91% of Total Assets)

Name Symbol % Assets
PDD Holdings Inc ADR PDD 3.25%
Intuit Inc INTU 3.12%
NVIDIA Corp NVDA 3.03%
Atlassian Corp A TEAM 3.01%
Lam Research Corp LRCX 3.01%
Adobe Inc ADBE 2.96%
Cognizant Technology Solutions Corp Class A CTSH 2.89%
Applied Materials Inc AMAT 2.88%
Workday Inc Class A WDAY 2.88%
ON Semiconductor Corp ON 2.86%

QTEC pros

The following are QTEC strengths from our perspective:

  • QTEC 3-year return is 8.28%, which is higher than the 3-year return of the benchmark index (MSCI ACWI NR USD), 6.34%.
  • QTEC 5-year return is 12.94%, which is higher than the 5-year return of the benchmark index (MSCI ACWI NR USD), 6.51%.
  • QTEC 10-year return is 16.79%, which is higher than the 10-year return of the benchmark index (MSCI ACWI NR USD), 8.76%.
  • QTEC 15-year return is 12.23%, which is higher than the 15-year return of the benchmark index (MSCI ACWI NR USD), 4.59%.

QTEC cons

The following are QTEC weaknesses from our perspective:

  • QTEC net assets are $0.00 million. This fund is not a popular choice with retail investors.
  • QTEC expense ratio is 0.57%, which is not negligible. Is the fund expensive to you, and does it align to your investment strategy?

Other relevant QTEC comparisons

You may also want to check out the following QTEC comparisons that investors often look for on Finny

Or use Finny's Comparison Tool to create a comparison you'd like to see.

RYT

RYT description

Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company’s lead product candidate is IMCIVREE, a rare melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1, leptin receptor (LEPR) deficiency obesity, and Bardet-Biedl and Alström syndrome. It is also developing setmelanotide, which is in Phase 3 clinical trials for treating POMC or LEPR heterozygous deficiency obesities, steroid receptor coactivator 1 deficiency obesity, SH2B1 deficiency obesity, MC4 receptor deficiency obesity, and other MC4R disorders. The company was formerly known as Rhythm Metabolic, Inc. and changed its name to Rhythm Pharmaceuticals, Inc. in October 2015. Rhythm Pharmaceuticals, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

RYT performance & returns

YTD Return 19.34%
1-Month Return 11.43%
3-Month Return 13.24%
1-Year Return 17.05%
3-Year Return 15.06%
5-Year Return 12.93%
10-Year Return 17.54%
RYT expense ratio is 0.4%.

RYT holdings

Top 10 Holdings (19.18% of Total Assets)

Name Symbol % Assets
NVIDIA Corp NVDA 2.35%
Advanced Micro Devices Inc AMD 2.04%
Microsoft Corp MSFT 1.88%
Broadcom Inc AVGO 1.88%
ServiceNow Inc NOW 1.87%
Salesforce Inc CRM 1.84%
Lam Research Corp LRCX 1.84%
Tyler Technologies Inc TYL 1.83%
Synopsys Inc SNPS 1.83%
Akamai Technologies Inc AKAM 1.83%

RYT pros

The following are RYT strengths from our perspective:

  • RYT 3-year return is 15.06%, which is higher than the 3-year return of the benchmark index (MSCI ACWI NR USD), 6.34%.
  • RYT 5-year return is 12.93%, which is higher than the 5-year return of the benchmark index (MSCI ACWI NR USD), 6.51%.
  • RYT 10-year return is 17.54%, which is higher than the 10-year return of the benchmark index (MSCI ACWI NR USD), 8.76%.
  • RYT 15-year return is 11.16%, which is higher than the 15-year return of the benchmark index (MSCI ACWI NR USD), 4.59%.

RYT cons

The following are RYT weaknesses from our perspective:

  • RYT net assets are $0.00 million. This fund is not a popular choice with retail investors.

Other relevant RYT comparisons

You may also want to check out the following RYT comparisons that investors often look for on Finny

Or use Finny's Comparison Tool to create a comparison you'd like to see.
You can check out all comparisons Finny users have looked for here. Feel free to the browse the list and view the comparisons that are of an interest to you.